Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Morphine versus oxycodone for cancer pain: genetic determinants of opioid response
2005-001660-31Phase 4Completed
- Sponsor
- Royal Marsden NHS Foundation Trust
- Start
- Jul 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in cancer pain comparing Morphine arm with Oxycodone arm (2 arms). Primary endpoint: Responder rate to morphine and oxycodone as first-line opioids. Started Jul 2005; status: completed.
02
Drugs
oxycodonemorphine
03
Conditions
cancer pain
Beyond the preview
Go deeper on 2005-001660-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-001660-31.